Show simple item record

dc.contributor.authorRedin, A.
dc.contributor.authorCiruela, P.
dc.contributor.authorDe Sevilla, M. F.
dc.contributor.authorGomez-Bertomeu, F.
dc.contributor.authorGonzalez-Peris, S.
dc.contributor.authorBenitez, M. A.
dc.contributor.authorTrujillo, G.
dc.contributor.authorDiaz, A.
dc.contributor.authorJou, E.
dc.contributor.authorIzquierdo, C.
dc.contributor.authorPerez-Moreno, M. O.
dc.contributor.authorMoraga-Llop, F.
dc.contributor.authorOlsina, M.
dc.contributor.authorVinado, B.
dc.contributor.authorSanfeliu, E.
dc.contributor.authorGarcia, A.
dc.contributor.authorGonzalez-di Lauro, S.
dc.contributor.authorGarcia-Garcia, J. J.
dc.contributor.authorDominguez, A.
dc.contributor.authorSa-Leao, R.
dc.contributor.authorMuñoz Almagro, Carmen
dc.contributor.authorCatalan Study Group of Invasive Pneumococcal DiseaseSHOW FEWER
dc.date.accessioned2022-01-20T12:12:43Z
dc.date.available2022-01-20T12:12:43Z
dc.date.issued2021
dc.identifier.citationRedin, A.; Ciruela, P.; De Sevilla, M. F. [et al.]. Serotypes and clonal composition of streptococcus pneumoniae isolates causing IPD in children and adults in Catalonia before 2013 to 2015 and after 2017 to 2019 systematic introduction of PCV13. Microbiology Spectrum, 2021, 9(3), e01150-21. Disponible en: <https://journals.asm.org/doi/10.1128/Spectrum.01150-21>. Fecha de acceso: 20 ene. 2022. DOI: 10.1128/Spectrum.01150-21.ca
dc.identifier.issn2165-0497ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/3088
dc.description.abstractThe goal of this study was to investigate the distribution of serotypes and clonal composition of Streptococcus pneumoniae isolates causing invasive pneumococcal disease (IPD) in Catalonia, before and after systematic introduction of PCV13. Pneumococcal strains isolated from normally sterile sites obtained from patients of all ages with IPD received between 2013 and 2019 from 25 health centers of Catalonia were included. Two study periods were defined: presystematic vaccination period (2013 and 2015) and systematic vaccination period (SVP) (2017 to 2019). A total of 2,303 isolates were analyzed. In the SVP, there was a significant decrease in the incidence of IPD cases in children 5 to 17 years old (relative risk [RR] 0.61; 95% confidence interval [CI] 0.38 to 0.99), while there was a significant increase in the incidence of IPD cases in 18- to 64-year-old adults (RR 1.33; 95% CI 1.16 to 1.52) and adults over 65 years old (RR 1.23; 95% CI 1.09 to 1.38). Serotype 8 was the major emerging serotype in all age groups except in 5- to 17-year-old children. In children younger than 5 years old, the main serotypes in SVP were 24F, 15A, and 3, while in adults older than 65 years they were serotypes 3, 8, and 12F. A significant decrease in the proportions of clonal complexes CC156, CC191, and ST306 and an increase in those of CC180, CC53, and CC404 were observed. A steady decrease in the incidence of IPD caused by PCV13 serotypes indicates the importance and impact of systematic vaccination. The increase of non-PCV13 serotypes highlights the need to expand serotype coverage in future vaccines and rethink vaccination programs for older adults. IMPORTANCE We found that with the incorporation of the PCV13 vaccine, the numbers of IPD cases caused by serotypes included in this vaccine decreased in all of the age groups. Still, there was an unforeseen increase of the serotypes not included in this vaccine causing IPD, especially in the >65-year-old group. Moreover, a significant increase of serotype 3 included in the vaccine has been observed; this event has been reported by other researchers. These facts call for the incorporation of more serotypes in future vaccines and a more thorough surveillance of the dynamics of this microorganism.en
dc.format.extent14ca
dc.language.isoengca
dc.publisherAmerican Society for Microbiologyca
dc.relation.ispartofMicrobiology Spectrumca
dc.relation.ispartofseries9;3
dc.rights© 2021 Redin et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International license.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.otherSerotipsca
dc.subject.otherStreptococcus pneumoniaeca
dc.subject.otherMalaltia pneumocòcica invasivaca
dc.subject.otherVacunacióca
dc.subject.otherVacunació presistemàticaca
dc.subject.otherVacunació sistemàticaca
dc.subject.otherSerotiposes
dc.subject.otherStreptococcus pneumoniaees
dc.subject.otherEnfermedad neumocócica invasivaes
dc.subject.otherVacunaciónes
dc.subject.otherVacunación presistemáticaes
dc.subject.otherVacunación sistemáticaes
dc.subject.otherSerotypesen
dc.subject.otherStreptococcus pneumoniaeen
dc.subject.otherInvasive pneumococcal diseaseen
dc.subject.otherVaccinationen
dc.subject.otherPresystematic vaccinationen
dc.subject.otherSystematic vaccinationen
dc.titleSerotypes and clonal composition of streptococcus pneumoniae isolates causing IPD in children and adults in Catalonia before 2013 to 2015 and after 2017 to 2019 systematic introduction of PCV13en
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc61ca
dc.identifier.doihttps://dx.doi.org/10.1128/Spectrum.01150-21ca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

© 2021 Redin et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint